𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation

✍ Scribed by Kitabayashi, I.


Book ID
111745438
Publisher
Nature Publishing Group
Year
1998
Tongue
English
Weight
535 KB
Volume
17
Category
Article
ISSN
0261-4189

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Roles of p15Ink4b and p16Ink4a in myeloi
✍ Rose M. Ko; Hyung-Gyoon Kim; Linda Wolff; Christopher A. Klug πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 967 KB

Inactivation of p15(Ink4b) expression by promoter hypermethylation occurs in up to 80% of acute myeloid leukemia (AML) cases and is particularly common in the FAB-M2 subtype of AML, which is characterized by the presence of the RUNX1-ETO translocation in 40% of cases. To establish whether the loss o

Reversal of p15/INK4b hypermethylation i
✍ Tobias Berg; Yalin Guo; Mahmoud Abdelkarim; Manfred Fliegauf; Michael LΓΌbbert πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 802 KB

In vitro and in vivo, myeloid leukemic and preleukemic cells exhibit variable sensitivity to the antiproliferative and proapoptotic effects induced already at low concentrations of DNA methyltransferase (DNMT) inhibitors. The molecular mechanisms underlying this variable sensitivity of leukemic blas

Bcr-Abl oncogene stimulates jab1 express
✍ Kuei-Ting Yang; Ming-Chung Wang; Jing-Yi Chen; Ming-Chuan Hsu; Wen-Chun Hung πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 384 KB

## Abstract Jab1, a co‐activator of AP‐1 transcription factor and the fifth subunit of the COP9 signalosome, mediates degradation of the tumor suppressor p53 and p27^Kip1^ and functions as a tumor promoter in different types of human cancer. In this study, we show that inhibition of Bcr‐Abl oncogen